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Abstract 
The concept of DNAzyme-based gene silencing via mRNA cleavage was proposed over twenty 
years ago. A number of studies regarding intracellular gene silencing have been reported as well. 
However, questions have been raised regarding the lack of enzyme activity in physiological buffer 
conditions and it is being doubted that in the previously reported studies, gene silencing might be 
simply due to an antisense effect. In this work, two classical DNAzymes for RNA cleavage are 
studied using both chimeric substrates and extracted mRNA. We concluded that the activity of the 
8-17 DNAzyme is much higher than that of 10-23 in the same conditions. To illustrate and compare 
the effect of specific cleavage versus antisense effect in the best possible way, we used tandem 
DNAzymes. Specific mRNA cleavage occurred with Zn2+, while with Mg2+, even the inactive 
control DNAzymes showed a similar response, suggesting that the antisense effect might be the 
dominating phenomenon causing gene silencing. This study has thus clarified the choice of 
DNAzyme sequence, the effect of metal ions and a potential source of antisense effect. 
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A number of strategies have been developed to selectively cleave mRNA for anti-viral and anti-
cancer applications.1 For example, antisense DNA relies on DNA oligomers to form a duplex with 
target mRNA and recruit RNase H to cleave the RNA strand.2 With siRNA, the cellular RNA 
interference pathway is harnessed and the target mRNA is efficiently degraded.3 Ribozymes are 
RNA-based enzymes and many naturally occurring ribozymes have RNA cleavage activity. A few 
artificial ribozymes have also been engineered to cleave mRNA without the involvement of protein 
components.4 However, RNA has low stability and is easily degraded.5 DNAzymes are DNA-
based enzymes.6-10 Since first report in 1994,11 DNAzymes have been proposed to cleave 
mRNA.12-14 DNAzymes can execute the same catalytic function as ribozymes but are more stable, 
cost-effective and easier to label.6-10  
In 1997, Santoro and Joyce reported two general-purpose RNA-cleaving DNAzymes that 
cleave all-RNA substrates with efficiency comparable to  that of protein enzymes.7, 15 Out of the 
two, the 10-23 DNAzyme has been widely studied for intracellular mRNA cleavage.13, 16-18 This 
is probably because of its excellent substrate generality, it cleaves any purine/pyrimidine 
junctions,7 which offers tremendous freedom  to  target  many regions of interest within an mRNA. 
The other one, the 8-17 DNAzyme, has been more researched upon for metal detection since it has 
excellent activity in the presence of low concentrations of Pb2+.19 At the same time, it is also studied 
as a model DNAzyme due to its recurrence in many different in vitro selections and high catalytic 
efficiency.20-25 Examples of using the 8-17 DNAzyme for gene silencing are also known.18, 26 
While many examples of DNAzyme-based intracellular mRNA cleavage are reported,13 
concerns have also been raised that the 10-23 DNAzyme is basically inactive with physiological 
concentrations of free Mg2+.27, 28 Biochemical and spectroscopic studies suggest that previously 
reported 10-23 DNAzyme induced gene silencing might be simply due to an anti-sense effect 
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instead of DNAzyme-induced cleavage.29, 30 Since most of the previous gene silencing work only 
measured the final mRNA or protein concentration, while the step-by-step reaction processes were 
not followed, the exact role of the DNAzymes remains elusive.13 To move forward, a clear 
understanding on the reaction steps of DNAzyme catalysis is needed. Herein, we perform a few 
comparisons between the 10-23 and 8-17 DNAzymes and aim to answer the following questions 
related to mRNA cleavage: 1) the optimal DNAzyme to be used, 2) the DNAzyme activity in the 
presence of different metal ions, and 3) the antisense effect versus DNAzyme-induced cleavage.  
The secondary structures of the 8-17 and 10-23 DNAzymes are shown in Figure 1A and 
1B respectively. For each DNAzyme, the substrate strand contains a single RNA linkage that can 
be cleaved by the enzyme strand in the presence of divalent metal ions. In the original paper, the 
10-23 DNAzyme was described to cleave rRY (R = A, G; Y = T, C) junctions (Figure 1B has an 
rGT junction).7 The 8-17 DNAzyme cleaves the rAG junction, and appeared to be less general 
during its initial studies. However, after extensive selection and mutation work, the Li group 
discovered that the 8-17 DNAzyme can cleave essentially all the 16 possible dinucleotide junctions, 
although the rate varies over 5 orders of magnitude for these junctions.21 By introducing mutations 
in the enzyme, the 8-17 DNAzyme can be optimized for each type of junction. It was recently 
proposed that the 8-17 and 10-23 DNAzymes might be the same enzyme.31 In other words, the 10-
23 DNAzyme might be a mutant of the 8-17.31 This conclusion was made based on mutation 
studies. We are interested in testing their activity in the presence of different metal ions.  
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Figure 1. The secondary structure of the (A) 8-17 and (B) 10-23 DNAzymes. By mutating the T 
(in blue) to C for the 8-17 or C to T and G to C for the 10-23, inactive DNAzymes are generated. 
(C) A gel picture of the 10-23 DNAzyme cleavage in the presence of 0.1 mM divalent metal ions. 
Cleavage rates of (D) the two DNAzymes in the presence of different concentrations of Mg2+, (E) 
the 10-23 DNAzyme and  (F) the 8-17 DNAzyme in presence of different divalent metal ions at 
various concentrations. All the reactions were carried out at pH 7.4 except for Pb2+ at pH 6.0 (the 
last bar in Figure 1E and 1F).    
 
Divalent metal ions are an indispensable part of DNAzyme catalysis,32-34 and a key concern 
raised is the activity of the 10-23 DNAzyme in physiological Mg2+ concentrations.27, 28 To fully 
understand this, we first reacted the 10-23 DNAzyme with various other divalent metals for 1 h 
and the products were analyzed using gel electrophoresis (Figure 1C).  Since one end of the 
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substrate was labeled with a carboxyfluorescein (FAM), a darker lower band indicates more 
cleavage. Pb2+ induced the most cleavage, which was the same as the 8-17 DNAzyme.23 To have 
a quantitative comparison, we further measured the enzyme rate in the presence of these metal ions 
(Figure 1E). Pb2+ has the highest activity followed by transition metals such as Mn2+ and Zn2+ 
(note that Mg2+ and Ca2+ were  used at  a much higher concentration). It is not surprising that the 
10-23 DNAzyme has the highest activity with Pb2+ since both DNAzymes share the same 
conserved nucleotides.31 If we compare both, the 8-17 DNAzyme exhibits a similar trend but is 
~100-fold more active at the same metal concentrations (Figure 1F, note the difference in the scale 
of the y-axis). The significance of the similar trend observed in the above experiment also lies in 
the fact that it supports the theory that these two DNAzymes might belong to the same family and 
undergo the similar cleavage mechanism.  
For mRNA cleavage, the most important metal ion is Mg2+, since this is the most abundant 
divalent metal ion inside cells.35 Other metal ions, although yield faster cleavage, are not present 
as free ions in cells at useful concentrations.35 Next we compared the DNAzyme activity in the 
presence of low concentrations of Mg2+ (Figure 1D). Both DNAzymes showed Mg2+ 
concentration-dependent activity. Again, the 8-17 was ~100-fold more active. For mRNA cleavage, 
we need to use the most efficient DNAzyme. Therefore, the 8-17 DNAzyme is likely to be a better 
choice. Among the four junctions that the 10-23 DNAzyme can cleave, this rGT junction is a 
relatively easily cleavable one. For example, when an rAC junction was used, barely any cleavage 
was observed even with 500 mM Mg2+ (Figure S1, ESI). Therefore, it is also true for the 10-23 
DNAzyme that its cleavage activity for every junction is not the same. 
The above work was carried out using RNA/DNA chimeric substrates, and the activity for 
cleaving pure RNA might be different. To further compare the DNAzymes for RNA cleavage, we 
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used mRNA as substrate. Since cleaving mRNA inside cells requires DNAzyme delivery and it is 
more difficult to draw quantitative conclusions, we started with extracted mRNA. We chose to 
target the mRNA for glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which is an abundant 
house-keeping gene. After PCR primer optimization, we fixed a region of the mRNA to target (see 
Figure S2 for real-time PCR quantification). In this mRNA fragment (Figure 2A), two cleavage 
sites were identified, one to be targeted by the 10-23 DNAzyme (called 23E1, see Figure S3 in 
ESI for sequence) and the other by the 8-17 DNAzyme (17E1). These two sites are only four 
nucleotides apart, therefore the effect from mRNA secondary structure should be minimal.  
 
 
 
Figure 2. (A) A fraction of the GAPDH mRNA sequence with the PCR primer binding region in 
blue. The DNAzyme targeted cleavage junctions are shown before the parenthesis indicating the 
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name of the enzyme. (B) Cleavage of the mRNA by 17E1 or 23E1 in the presence of different 
metal ions for 1 h. (C) Cleavage by the different DNAzymes as a function of time with 2 mM Mg2+. 
 
The extracted total RNA was mixed with each DNAzyme in presence of 2 mM Mg2+ for 1 
h. After reaction, the products were reverse transcribed into cDNA and then quantified using real-
time (RT) PCR, which is the typical protocol for mRNA quantification in gene silencing work. To 
ensure that the measurement was made on cleavage instead of artifacts, mutated control 
DNAzymes were also included (mutated nucleotides are indicated in blue in Figure 1A, B). These 
mutated nucleotides are known to be critical for activity. To highlight the effect of cleavage, all 
the samples were normalized against their control DNAzyme (Figure 2B). The decrease of mRNA 
was only ~10% for the 23E1 DNAzyme and this difference was statistically insignificant 
considering the error bars. On the other hand, 20-30% decrease was achieved with 17E1 using the 
same Mg2+ concentration and ~50% decrease was achieved with 0.5 mM Zn2+. Next, we studied 
time-dependent mRNA cleavage using 2 mM Mg2+ (Figure 2C). For all the samples, we observed 
more cleavage with time and the 17E1 always exhibited more cleavage. This comparison also 
supports that the 8-17 DNAzyme can be better at cleaving mRNA. 
After determining the best enzyme, we next aim to further increase the cleavage yield. 
Since an mRNA is quite long and cleavage at any point destroys its function, a method to increase 
cleavage is to use a few DNAzymes simultaneously to target different positions along the mRNA. 
To test this, we designed three 8-17 DNAzymes (named 17E1, 17E2 and 17E3, Figure 2A). For 
each DNAzyme, a corresponding inactive mutant was used as control. These DNAzymes target 
the GG dinucleotide junctions to achieve a high cleavage activity.21 Since the PCR primers cover 
the whole region, any cleavage should result in the signal suppression. To avoid artifacts due to 
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DNAzyme concentration, all the samples contained the same amount of total DNAzyme (e.g. 100 
nM of each of 17E1, 2, and 3 when all were used together; or 150 nM of both 17E1 and 2 when 
only the two were used together; or 300 nM 17E1 if it was the only DNAzyme used). In addition, 
a sample without DNAzyme treatment was also analyzed as the reference standard for comparison. 
Here, we aim to compare both non-specific (e.g. antisense) and specific (cleavage) effects of the 
added DNAzymes, and the data was normalized against the untreated samples (instead of control 
DNAzymes). In the presence of 0.5 mM Zn2+, none of the inactive control DNAzymes produced 
much cleavage and nearly 100% mRNA remained for all the samples (Figure 3A, red bars), 
suggesting that the DNAzymes did not cause non-specific effects. In most cases, samples with the 
active DNAzymes (black bars) produced more mRNA cleavage compared to the control 
DNAzymes. We also observed that more the number of DNAzyme added, more was the inhibition 
effect (Figure 3A, the average of the two combined has ~34% more inhibition than the average of 
the three individual ones; the three combined has the largest inhibition effect). Therefore, the 
tandem DNAzymes can promote mRNA cleavage. 
When the same reactions were carried out in the presence of 2 mM Mg2+, however, a 
completely different pattern was observed (Figure 3B). The full mRNA concentration measured 
from RT-PCR dropped significantly as the number of DNAzymes increased (red bars). Since these 
are inactive DNAzymes, the observed decrease in the RT-PCR signal cannot be attributed to 
cleavage, and we attribute this to a simple antisense effect. On the other hand, the signal from the 
active DNAzymes (black bars) are similar to that from the inactive controls (red bars) in most 
cases, especially when mixed DNAzymes were used, suggesting that the specific cleavage related 
events were insignificant. In both studies, 17E3 (the last set of bars) showed a similar activity 
between the real enzyme and control, indicating that targeting this position by the DNAzyme was 
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ineffective. This might be related to some stable secondary structures in the mRNA, hindering 
DNAzyme binding. 
When multiple DNAzymes are used in tandem, two effects may have taken place. First, 
after hybridizing with the first DNAzyme, hybridization with the subsequent ones could become 
easier, since the first DNAzyme may break possible local secondary structures. Thus, if cleavage 
reaction can take place, there should be synergistic effects to increase the level of cleavage. Second, 
once such DNAzyme binding structures are formed, especially in tandem, they may pose a steric 
barrier for subsequent reactions to measure mRNA, namely the reverse transcription reaction. This 
blocking effect can be described to be a type of antisense effect.  
In this study, Zn2+ was used because it is more active at low metal concentrations. So, its 
effect on ionic strength change is small and we can better probe the DNAzyme cleavage activity. 
Mg2+ was used because it is believed to be the most relevant metal inside cells. Mg2+ is also highly 
effective in stabilizing DNA duplex, which is consistent with the observed antisense effect. The 
antisense effect of DNAzymes is typically referred to the recruitment of RNase H inside cells, but 
this study suggests that other types of antisense effects along the whole assay process are also 
possible.  
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Figure 3. Cleavage of extracted mRNA using tandem 8-17 DNAzymes in the presence of (A) 0.5 
mM Zn2+ and (B) 2 mM Mg2+ for 1.5 h. Total DNAzyme concentration = 300 nM. Each DNAzyme 
is compared with an inactive control sequence. The difference between red and black bars accounts 
for mRNA cleavage. The suppression of the red bars is due to an antisense effect.  
 
In summary, we compared two classical DNAzymes with respect to their RNA cleavage 
activity. It is crucial to have control DNAzymes in mRNA cleavage studies. Otherwise, one cannot 
draw a conclusion that gene silencing is due to DNAzyme-induced cleavage instead of antisense 
effect. Second, while both DNAzymes have measurable activity in the presence of physiological 
concentration of Mg2+, the 8-17 DNAzyme is ~100-fold faster than the particular 10-23 DNAzyme 
for cleaving chimeric substrate. Since they are active also with other divalent metal ions (e.g. Zn2+), 
their actual activity in cells might be higher. Third, in the original paper,7 a major difference 
between these two DNAzymes is the substrate cleavage junction. The efficiency for cleaving 
different junctions by the 8-17 DNAzyme has been systematically studied.21 We show here that 
the 10-23 DNAzyme also cleaves different junctions quite differently. If we accept the notion that 
both DNAzymes belong to the same family, and each junction may have its own optimal substrate 
junction sequence for cleavage, these two classic DNAzymes are just two examples of this 
DNAzyme family. Instead of focusing on which between the two should be used, it is probably 
more important to look at the dinucleotide junction at the targeted cleavage site, and then to find 
the optimal enzyme sequence.21 
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